Detalles de la búsqueda
1.
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.
Eur Heart J
; 34(11): 835-43, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23293303
2.
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.
Heart Fail Rev
; 17(3): 485-509, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21932146
3.
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
Eur Heart J
; 32(20): 2563-72, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21785107
4.
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
Am Heart J
; 159(5): 841-849.e1, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20435194
5.
Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction.
Am J Ther
; 17(4): e78-87, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20634650
6.
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.
JAMA
; 299(22): 2656-66, 2008 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18544725
7.
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
J Am Coll Cardiol
; 52(20): 1640-8, 2008 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18992654
Resultados
1 -
7
de 7
1
Próxima >
>>